Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine

This study has been completed.
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Alkermes, Inc. Identifier:
First received: June 2, 2011
Last updated: March 8, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)